Resources

For the latest in nextgen biomed, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox

Immunotherapy (Non-Oncology)

Scientists Develop First Mouse Model with Complete & Functional Human Immune System

The breakthrough in mouse models will allow researchers to study the human immune system in far greater detail at a far greater pace.
Manufacturing & Bioprocessing

SGS Cell & Gene Therapies

NextGen Therapeutics

GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection

CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.
Immuno-Oncology

Unlocking the Future of Immune Cancer Therapy

A concise report featuring insights from the prominent though leaders of Immuno 2024.
Bioanalysis

2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins

Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.
Bioanalysis

Looking Back on the 2002 Nobel Prize for Chemistry: Mass Spectrometry for the Analysis of Proteins

2002's Nobel Prize for Chemistry recognised the translation of mass spectrometry to large molecules which has been instrumental in unlocking the proteome toward new therapies.
Cancer Vaccines

NHS Cancer Vaccine Launchpad to Give Thousands Access to Personalised Cancer Vaccines

NHS England aims to match up to 10,000 cancer patients to suitable personalised cancer vaccine clinical trials by 2030.
Antibody & Protein Engineering

Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges

A concise report featuring insights from the prominent thought leaders of Biologics 2024
Manufacturing & Bioprocessing

Is Single-Use Bioprocessing the Way Forward?

Danish company Novo Holdings has acquired a majority stake in the Austrian-based company Single Use Support, marking a critical stride towards the wider adoption of single-use bioprocessing tools.
Biomarkers & Precision Medicine

AI-Enabled Predictive Biomarker for Patient Response to Immunotherapy Using Easy-to-Measure Features

The predictive biomarker does not require multi-omic or screening data, but rather routine clinical features.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things discovery